替卡格雷杂质 替格瑞洛杂质 对照品现货

替卡格雷杂质 替格瑞洛杂质 对照品现货 产品介绍：
中文名称：替卡格雷杂质 替格瑞洛杂质 对照品现货
英文名称：Ticagrelor Impurity
规格：10mg/25mg/50mg/100mg等多种规格可选。
用途：实验研发，药品申报检测，不得用于临床医学诊断。
随货提供：所有杂质对照品均随货提供HPLC，NMR，MS图谱及CoA证书。
保存及取用：为了防止产品含量降低，应防潮，避光和抗氧化包装，保存应以提高物质稳定性为原则。如果一次使用很少量，可以将其适当分装后使用，这样可以有效的防止试剂污染。请不要在脏乱和强光环境中取用，以免造成污染和失效。
 
替卡格雷杂质 替格瑞洛杂质 对照品现货 杂质列表：
Ticagrelor
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 1
(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 2
(1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 3
(1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 4（Mixture of Diastereomers）
(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 5（Mixture of Diastereomers）
(1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 6
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
Ticagrelor Impurity 7
(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 8
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 9
2-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 10
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 11
2-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 12
(1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 13
5-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 14
(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 15
(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 16
2-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 17
(1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 18
(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 19
(1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 20
(1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol
Ticagrelor Impurity 21
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 22
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 23
sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate
Ticagrelor Impurity 24
(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 25
(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 26
2-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 27
(1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 28
7-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
Ticagrelor Impurity 29
(1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol
Ticagrelor Impurity 30
2-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

若杂质列表中未有您需要的杂质，欢迎来电或在线详询，产品库时常会有更新，另外，我司有专业研发团队，可提供部分杂质定制服务，以可能的满足您对杂质对照品的选购需求。
 
替卡格雷杂质 替格瑞洛杂质 对照品现货 订购方式：
联系人：何先生
手机：15012456311
QQ：781007885
邮箱：phastandards@gmail.com
欢迎您通过电话，电邮或在线客服向我司询价及订购产品。
 
替卡格雷杂质 替格瑞洛杂质 对照品现货 深圳远扬专注医药标准品，杂质对照品，更多产品，欢迎选购（篇幅有限，只列举了一小部分，更多更全，请来电详询）：
NIBSC标准品部分产品列表：
 01/457 Meningococcal serogroup W polysaccharide
01/450 Meningococcal serogroup W polysaccharide
01/498 Meningococcal serogroup W polysaccharide
95/611 Interleukin-72 (Human, rDNA derived)
07/365 BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent)
13/296 Polio Anti Sabin type 79 (inactivated) Serum
12/B623-066 QCRFLUAH1N1QC1-Influenza AH1N1 QC64
03/104-069 HTLV-54 (antibody) Monitor Sample
13/233 Polio Anti Sabin type 16 (inactivated) Serum
10/183 Reteplase Reference Material
10/181 Reteplase Reference Material
03/104-122 HTLV-107 (antibody) Monitor Sample
01/514 Meningococcal serogroup W polysaccharide
01/516 Meningococcal serogroup W polysaccharide
13/144 Influenza Antigen B/Massachusetts/02/2022 (Egg derived)
13/145 Influenza Antigen B/Massachusetts/02/2023 (Egg derived)
95/658 Interleukin-119 (Human, rDNA derived)
95/569 Interleukin-30 (Human, rDNA derived)
12/B623-106 QCRFLUAH1N1QC1-Influenza AH1N1 QC104
13/146 Influenza Antigen B/Massachusetts/02/2024 (Egg derived)
13/176 C-Peptide, Human. 31st International Standard.
13/288 Polio Anti Sabin type 71 (inactivated) Serum
07/306 BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent)
01/525 Meningococcal serogroup W polysaccharide
95/587 Interleukin-48 (Human, rDNA derived)
12/B623-065 QCRFLUAH1N1QC1-Influenza AH1N1 QC63
13/222 Polio Anti Sabin type 5 (inactivated) Serum
03/104-077 HTLV-62 (antibody) Monitor Sample
12/B623-052 QCRFLUAH1N1QC1-Influenza AH1N1 QC50
 
替卡格雷杂质 替格瑞洛杂质 对照品现货 美国剑桥CIL标准品部分产品列表：
 DLM-9126-0.002   VITAMIN E (ALPHA-TOCOPHEROL) (5-METHYL-D3,7-METHYL-D3, 98%)
DLM-4365-PK   DIETHANOLAMINE (ETHYLENE-D8, 98%)
DLM-2497-1   MIXED FATTY ACID METHYL ESTERS (U-D, 96-98%)
EC-5414-CS3   MONO-DECA + PREDOMINANT PCB CALIBRATION SOLUTION CS3 (UNLABELED/13C12, 99%)
CLM-1577-PK   SODIUM L-LACTATE (1-13C, 99%) 20% W/W IN H2O
EF-5266-1.2   OCTABROMODIBENZOFURAN (13C12, 99%) 5 UG/ML IN NONANE:TOLUENE (70:30)
SELM-3695-PK   SELENIUM-74 METAL (74Se)
M-051   MESCALINE:HCL (D9, 98%) 100 UG/ML IN METHANOL (AS FREE BASE)
N-911   NORDIAZEPAM (D5, 98%) 1.0 MG/ML IN METHANOL
CLM-1604-0   DIFLUOROMETHANE (13C, 99%)
DLM-1819-0.5   DL-COTININE (METHYL-D3, 98%)
CNLM-7807-PK   L-METHIONINE (1-13C, 99%; 15N, 98%)
ERLM-3584-0   ERBIUM-170 OXIDE (170Er2)
PCB-74   2,4,4',5-TETRACB UNLABELED 35 UG/ML IN ISOOCTANE
DLM-6-S-50   DEUTERIUM OXIDE "" (D, 99.96%); SERUM BOTTLE
DLM-1136-5   ISOPROPANOL (DIMETHYL-D6, 98%)
CLM-206-MPT   L-METHIONINE (METHYL-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED
CNLM-3871-H-PK   L-CYSTEINE (13C3, 99%; 15N, 99%)
CLM-1836-1.2   3,4,5-TRIBROMOPHENOL (13C6, 98%) 100 UG/ML IN TOLUENE
DLM-2066-1   ALGAL LYOPHILIZED CELLS (U-D, 98%)
DLM-1934-0.25   1,1-DICHLOROETHANE (2,2,2-D3, 98%)
CLM-1804-1.2   2,4,6-TRICHLOROPHENOL (13C6, 99%) 100 UG/ML IN METHANOL
BDE-37-CS   3,4,4'-TRIBDE (BDE-37) 50 UG/ML IN NONANE UNLABELED CERTIFIED STANDARD
ERP-053   METHOD 1666 SECONDARY STOCK STANDARD 2
E-021   EDDP PERCHLORATE (D3, 98%) 100 UG/ML IN METHANOL
P-044   PROMETHAZINE X HCL UNLABELED
DLM-280-PK   GLYCINE (D5, 98%)
EDF-5331-CS3L   MODIFIED JIS LOW CONCENTRATION DIOXIN & FURAN CALIBRATION SOLN CS3L (UNLABELED/13C12, 99%)
PCB-59   2,3,3',6-TETRACB UNLABELED 35 UG/ML IN ISOOCTANE
NLM-3899-CA-10   2'-DEOXYGUANOSINE:H2O (15N5, 98%) 95%+ CHEMICAL PURITY
CLM-1017-MPT-PK   GLYCINE (1,2-13C2, 97-99%) MICROBIOLOGICAL/PYROGEN TESTED
CLM-8931-0.1MG   L-THYROXINE (RING-13C12, 99%) CP 97%
CDLM-8100-PK   ALPHA-KETOISOVALERIC ACID, SODIUM SALT (1,2,3,4-13C4, 99%; 3,4',4',4'-D4, 97-98%)
WG-1228-8   WILMAD N51A GLASS ECONOMY 5 MM 8" 400 MHZ NMR TUBE
ERLM-4494-0   ERBIUM-166 OXIDE (166Er2)
DLM-24TB-S-PK   METHANOL-D4 (D, 99.8%) +0.05% V/V TMS (IN SERUM BOTTLE)
CGM-2000-N-S   BIOEXPRESS-2000 (INSECT CELL) (U-15N, 98%) (200 ML MEDIA KIT)
DLM-1592-PK   DIETHYL ETHER-D10 (D, 99%)